Alnylam Pharmace. sell Biotechhunter
Start price
28.08.20
/
50%
€111.24
Target price
03.09.20
-
Performance (%)
-4.98%
End price
03.09.20
€105.70
Summary
This prediction ended on 03.09.20 with a price of €105.70. With a performance of -4.98%, the SELL prediction by Biotechhunter was trending in the right direction. Biotechhunter has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -5.044% | -5.044% | 12.186% | 32.068% |
| iShares Core DAX® | 0.224% | 1.805% | 3.203% | 50.396% |
| iShares Nasdaq 100 | 6.047% | 15.716% | 39.608% | 108.035% |
| iShares Nikkei 225® | 5.724% | 12.343% | 50.337% | 73.481% |
| iShares S&P 500 | 2.172% | 7.723% | 26.167% | 72.779% |
Comments by Biotechhunter for this prediction
In the thread Alnylam Pharmace. diskutieren
Sell Alnylam Pharmace.